In metagenomic studies, testing the association between microbiome composition and clinical outcomes translates to testing the nullity of variance components. Motivated by a lung human immunodeficiency virus (HIV) microbiome project, we study longitudinal microbiome data by using variance component models with more than two variance components. Current testing strategies only apply to models with exactly two variance components and when sample sizes are large. Therefore, they are not applicable to longitudinal microbiome studies. In this paper, we propose exact tests (score test, likelihood ratio test, and restricted likelihood ratio test) to (a) test the association of the overall microbiome composition in a longitudinal design and (b) detect the association of one specific microbiome cluster while adjusting for the effects from related clusters. Our approach combines the exact tests for null hypothesis with a single variance component with a strategy of reducing multiple variance components to a single one. Simulation studies demonstrate that our method has a correct type I error rate and superior power compared to existing methods at small sample sizes and weak signals. Finally, we apply our method to a longitudinal pulmonary microbiome study of HIV-infected patients and reveal two interesting genera Prevotella and Veillonella associated with forced vital capacity. Our findings shed light on the impact of the lung microbiome on HIV complexities. The method is implemented in the open-source, high-performance computing language Julia and is freely available at https://github.com/ JingZhai63/VCmicrobiome.
This paper is motivated by longitudinal microbiome studies. For instance, the lung human immunodeficiency virus (HIV) microbiome project studies the respiratory microbiome of HIV-infected patients and how the highly active antiretroviral therapy (HAART) may alter its construction (Twigg et al., 2016) . A longitudinal cohort of HIV-infected subjects was collected before and up to 3 years after starting HAART. (1)
where y X G , , , and ε are the vertically stacked vectors/ matrices of individual-level y X G , , i i i , and ε i . y i is a vector of n i repeated measures of a quantitative phenotype for individual i. X i is the n p × i covariate matrix. G i is an n u × i operational taxonomic unit (OTU) abundance matrix for individual i where u is the total number of OTUs. These OTUs are related by a known phylogenetic tree. is an n × 1 i vector of the random error. Z is a block diagonal matrix with 1 n i on its diagonal. β is a p × 1 vector of fixed effects and b b = ( ) i is the subject-specific random effects. K is a kernel matrix capturing distances between individuals, for example, the UniFrac distance (Lozupone & Knight, 2005) or the Bray-Curtis dissimilarity (Bray & Curtis, 1957; Web Appendix A) . b G h , ( ) and ε are jointly independent; therefore, 
where σ d 2 is the phenotypic variance due to the correlation of repeated measurements, σ g 2 is the phenotypic variance explained by the microbiome, and σ e 2 is the within-subject variance that cannot be explained by the microbiome and repeated measurements. The detection of overall microbiome association is to test , Model (1) reduces to the microbiome regression-based kernel association test (MiRKAT; J. Chen, Chen, Zhao, Wu, & Schaid, 2016; Zhan et al., 2017; Zhao et al., 2015) . In the longitudinal setting, the extra variance component σ d 2 is necessary to capture the correlation between repeated measurements. After the overall association is identified, localization of the signal to a specific component of the microbial community is essential for downstream mechanistic studies and drug discoveries. For instance, Jangi et al. (2016) found that multiple sclerosis patients had significantly increased abundance of the phylum Euryarchaeota. However, such fine cluster effects can be tagged by other correlated microbials in the community (Gilbert et al., 2016) , leading to falsepositive discoveries. To detect association from specific taxonomic clusters, distances and kernel matrices can be formulated using abundances and tree information from specific clusters. Overall microbiome effects are then partitioned into different clusters at the same taxonomic level. That is, 
where
is the summation of all microbiome clusters. We are now interested in testing effects from a specific taxonomic cluster:
Current methods for testing the null variance component in Models (2) and (3) are based on either asymptotics or parametric bootstrap. Under the assumption that the response variable vector can be partitioned into independent subvectors and the number of independent subvectors is sufficient, asymptotic null distribution of the likelihood ratio, Wald, and score tests is available (Self & Liang, 1987; Silvapulle & Sen, 2011; Stram & Lee, 1994) . However, the asymptotic approximation deteriorates when the data are highly correlated without a sufficient number of independent blocks. Let m be the total number of phenotypic variance components except the error variance component. When m = 1, Crainiceanu and Ruppert (2004) developed a computational procedure for obtaining the approximate finite-sample distribution of the likelihood ratio and restricted likelihood ratio test (LRT) statistics. Greven, Crainiceanu, Küchenhoff, and Peters (2008) provided a pseudolikelihood-heuristic extension of this method to the m > 1 situation. Later Drikvandi, Verbeke, Khodadadi, and PartoviNia (2013) proposed a permutation test that does not depend on the distribution of the random effects and errors except for their mean and variance and can be applied to the m > 1 situation. However, the permutation test is computationally prohibitive for high dimensional tests. Qu, Guennel, and Marshall (2013) proposed a test statistic that is the weighted sum of the scores from the profile likelihood. Their method considered testing a subset of the variance components to be zero. When m = 1, Qu et al.'s (2013) method is exact; when m > 1, their test relies on asymptotic theory. Score-based tests can be less powerful than the LRTs, especially when sample sizes are limited as in most of the sequencing studies. Saville and Herring (2009) developed yet another type of test based on the Bayes factors using the Laplace approximation. It cannot be easily extended to multiple random effects and relies on the subjective choice of the prior distribution of parameters. Others have suggested procedures based on Markov chain Monte Carlo methods (Z. Chen & Dunson, 2003; Kinney & Dunson, 2007) , but they can be time-consuming, especially when the number of random effects is large.
In this study, we propose methods of performing the exact LRT (eLRT), the exact restricted LRT (eRLRT), and the exact score test (eScore) of a variance component being zero for the finite sample. Our approach combines the corresponding exact tests for the m = 1 case with a strategy of reducing the m > 1 case to the m = 1 case (Christensen, 1996; Ofversten, 1993) . Our method is the first one that provides the eLRT, eRLRT, and eScore for testing the zero variance component when multiple variance components are present (m > 1).
| METHODS

| Exact tests with one variance component under H 0
We briefly review the three exact tests, eLRT, eRLRT, and eScore, for testing H σ : and the eLRT and eRLRT (Crainiceanu & Ruppert, 2004) or the eScore test (Zhou, Hu, Qiao, Cho, & Zhou, 2016) can be applied to Ty.
Let λ σ σ = for i k n s = + 1,…, − , and they are jointly independent. The null distribution can be obtained from computer simulation. A computationally efficient χ 2 approximation algorithm is given in the Supporting Information Material (Web Appendix B). The same derivation can be carried out for the eRLRT, in which case
The null distribution generation for eRLRT is shown in Web Appendix B. Algorithms 1 and 2 in Web Appendix B contain a univariate optimization for each simulated point from the null distribution and can be computationally intensive for obtaining extremely small p-values.
To further reduce the computational burden, we adopt the Satterthwaite method to approximate the null distributions . For eScore, it is easier to work with the original
∂ ∂ are evaluated at the maximum likelihood estimator under the null. The resultant test rejects the null when ⎧ ⎨ ⎩ ⎫ ⎬ ⎭ y I P V I P y y I P y
be the positive eigenvalues of I P V I P ( − ) ( − )
where w i are n s − independent standard normals. The null distribution can be obtained from computer simulation or inverting the characteristic function . Both options, simulation and approximation of null distribution, are available in our program, https:// github.com/JingZhai63/VCmicrobiome.
| Exact tests with more than one variance component under H 0
In this section, we consider the situation when
. We follow a strategy to reduce the problem to the m = 1 Case 2 (Christensen, 1996; Ofversten, 1993) .
We first obtain an orthonormal basis Q Q Q Q ( , ,…, , ) , we use Q m−2 and so on. We consider the following cases: which is the case (4). The eLRT, eRLRT, and eScore can be applied without using the CQ y ′ m+1 piece.
where the scalar ζ is chosen such that
be the eigen-decomposition, ζ be the smallest positive eigenvalue, and C W δ ζ using the eLRT, eRLRT, or eScore test on the transformed data:
We note that if in some applications that matrices have high or full rank, consuming most or all available degrees of freedom after the above reduction strategy. One could proceed with a low rank approximation. For example, if m = 2 and V 1 has high or full rank, one could find the rank r V 1 approximation of V 1 as follows: Let V Q r = rank( ), 
| SIMULATION
We evaluate the performance of the exact tests for the longitudinal microbiome study in three simulation scenarios (Table 1) .
The longitudinal microbiome count data with two repeated measurements are simulated using the R package zero-inflated beta random effect (ZIBR) model (E. Z. . To mimic features of real microbiome datasets, the phylogenetic structure and average count information are extracted from the real HIV longitudinal pulmonary microbiome data. This microbiome data set contains 30 samples, each with 2-4 repeated measurements: baseline, 4 weeks, 1 year, and 3 years (Twigg et al., 2016) . OTU alignment at the species level was produced by software Mothur (https://www.mothur.org; Schloss et al., 2009 ) and the Basic Local Alignment Search Tool (BLAST; https://blast.ncbi.nlm.nih.gov/Blast.cg; Altschul, Gish, Miller, Myers, & Lipman, 1990) in the Ribosomal Database Project (RDP) 16S database release 11.4 (Maidak et al., 1996) . The phylogenetic tree at the OTU level is generated using the RDP classifier (Twigg et al., 2016) . We construct the higher taxon level, for example, phylum, using the phylogenetic tree generator phyloT (http://phylot.biobyte. de/; Letunic & Bork, 2007 . We set the within-individual variance to σ = 1 e 2 . For longitudinal data simulation, the between individual variance σ d 2 is set to 0.6. This corresponds to 60% of the overall baseline phenotypic variance (Twigg et al., 2016) .
| Scenario 1: Testing the overall microbiome effect
Longitudinal responses are generated using the model,
2 2 2 2 2 , where
2, 0.5, 1.0, and 1.5. We compare the performance of five different distance measures: unweighted UniFrac (Lozupone & Knight, 2005) , weighted UniFrac distance (Lozupone, Hamady, Kelley, & Knight, 2007) , variance adjusted weighted (VAW) UniFrac distance (Chang, Luan, & Sun, 2011) , and generalized UniFrac distance with parameter α = 0.0 and 0.5 (J. Chen et al., 2012 when the number of repeats > 1. There are 2,964 OTUs presented in the simulated count data. A phylogenetic tree generated using the real pulmonary microbiome data is used for kernel calculation and phenotype simulations. K W : weighted UniFrac kernel; K U : unweighted UniFrac kernel; K VAW : variance adjusted weighted UniFrac kernel; K α : generalized UniFrac kernels with α = 0 and 0.5 OTU: operational taxonomic unit.
| Scenario 3: Comparing with existing methods
We compare our method with MiRKAT (Zhao et al., 2015) and LinScore (Qu et al., 2013) . As MiRKAT can only be used for testing overall microbiome effects for cross-sectional designs, we first compare the three methods when σ = 0 d 2 . Responses are generated according to simulation Scenario 1, where σ = 0,…,1.5 g 2 . In Scenarios 1 and 2, the sample size is fixed at n = 100. In Scenario 3, we compare the performance of the three methods under sample sizes 20, 30, 50, and 100. The performance of five different kernels is compared in Scenario 1. For Scenarios 2 and 3, we focus on the weighted UniFrac distance kernel only, which demonstrates a higher power than the other kernels in Scenario 1. Thousand Monte Carlo replicates are generated for all simulations and we use the nominal significance level 0.05 to evaluate Type 1 error and power.
| RESULTS
| Simulation results
| Scenario 1: Testing the overall microbiome effect
The type I error rate of eRLRT, eLRT, and eScore tests with various distance kernel matrices using real longitudinal OTU count data are shown in Table 2 . Figure 1 shows the power comparison with different kernels. In Figure 1a ,c, five different kernels are constructed using OTU count data directly. In Figure 1b ,d, OTU counts are summarized at the phylum level for kernel calculations. Figure 1 shows that kernel type greatly impacts the power. The weighted UniFrac kernel yields the highest power and the unweighted UniFrac kernel has the least power (Figure 1a,c) . The pattern of the power increase with effect size differs according to which taxon-level count data are used to calculate the kernel. The power of five kernels became similar to each other in Figure 1b,d . Furthermore, the power of the unweighted UniFrac kernel K UW , which is the least powerful kernel in Figure  1a ,c, greatly improves in Figure 1b ,d. The reason is when the reads are summarized at the higher phylum level, the difference of abundance between each phylum is less notable. The less variability of abundance between lineages, the more similar the power of detecting microbiome association. As expected, reducing variance components leads to reduced degrees of freedom for association testing and the test is slightly less powerful in the longitudinal study compared to the cross-sectional study given the same effect size in this simulation. Table 3 shows the Type 1 error rates for testing the microbiome effect at the phylum level, with and without adjusting for the effect contributed by cluster, other. Most Type 1 error rates are inflated when not adjusting for cluster other effects. In the cross-sectional design, the Type I error rates of Bacteroidetes and Proteobacteria stay correct due to its weak correlation with cluster other (Pearson correlation = 0.04, 0.11 with p = 0.70, 0.24, respectively). After adjustment, Type 1 error rates stay correct even when confounding effects are large (Table 3) .
| Scenario 2. Localizing fine microbiome cluster effects
In practice, symbiosis of bacteria causes correlation between them (Dickson, Erb-Downward, & Huffnagle, 2013; Xu et al., 2007; Zeng et al., 2016) . Precise medication that targets specific pathogens can minimize the damage to essential symbiotic microbial species, and preserve community structure and function in the healthy (and developing) microbiome (Blaser, 2016; Hicks, Taylor, & Hunkler, 2013) . Simulation Scenario 2 demonstrates that our method is capable of localizing fine microbiome cluster effects. Table 4 presents the Type 1 error rate and power for eRLRT, eLRT, eScore, MiRKAT, and LinScore tests in detecting overall microbiome effects. The power is shown for both cross-sectional and longitudinal studies with sample size from 20 to 100. eRLRT and eLRT outperform LinScore and MiRKAT in baseline simulation studies. For repeated measurements, eRLRT outperforms LinScore under small sample sizes (e.g., n 50 ≤ ). Under sample size n = 100, eRLRT has similar or slightly higher power compared to LinScore when the association strength is weak. Microbiome studies usually have a limited sample size due to the high cost. The higher power of the exact tests at small sample sizes will be particularly valuable for biologists and physicians for identifying the associated microbiome clusters.
| Scenario 3: Comparing with existing methods MiRKAT and LinScore
| Analysis of longitudinal pulmonary microbiome data
It is well known that HIV infection is associated with alterations in the respiratory microbiome (Twigg et al., 2016) . However, due to limited investigation, the clinical implications of lung microbial dysbiosis are currently unknown. As an initial step to reveal the connection of the respiratory microbiome to pulmonary complications in HIV-infected individuals, we investigate the relationship between pulmonary function and the respiratory microbiota profiles in the bronchoalveolar lavage (BAL) fluid of 30 HIV-infected patients at the advanced stage (baseline mean CD4 count, 262 cells/mm 3 ). Their acellular BAL fluid was sampled at baseline, 4 weeks, 1 year, and 3 years. 16S rRNA gene sequencing technology was used to quantify pulmonary microbiota. The details of microbiome composition have been discussed in Section 2.3. Pulmonary function is measured by spirometry and diffusion capacity tests. Spirometry tests measure how much and how quickly air can move out of lung. Typical spirometry tests include forced vital capacity, forced expiratory volume in 1 s (FEV1), and average forced expiratory flow (FEF). Diffusion capacity of the lungs for carbon monoxide (DLCO) measures how much oxygen travels from the lung alveoli , and K VAW represent the generalized UniFrac distance with α = 0, 0.5, weighted UniFrac distance, unweighted UniFrac distance, and variance adjusted weighted UniFrac distance, respectively. eLRT: exact likelihood ratio test; eRLRT: exact restricted likelihood ratio test; eScore: exact score test; OTU: operational taxonomic unit to the blood stream. DLCO corrected for hemoglobin (DsbHb) and diffusion capacity corrected for alveolar volume and hemoglobin (DVAsbHb) are evaluated. Descriptive statistics of these measures are summarized in Web Appendix Table 1 .
Exact tests and LinScore are used to study the association. Associations with p values less than 0.05 are reported to be significant. Covariates include gender, race, smoking status, CD4 counts, and HIV virus load (Table 5 ). The missing covariate is imputed by its mean. For the overall microbiome association test, no tests find significant associations. However at the phylum level, Bacteroidetes shows a significant association with spirometry while Firmicutes shows a significant association with diffusing capacity measures. Similar results have been reported by Hewitt and Molyneaux (2017) and Tunney et al. (2013) . We then focus on analyzing genera from both phyla Bacteroidetes and Firmicutes given their important status in normal lungs (Cui et al., 2014) . Only by eRLRT and eScore, genus Prevotella, Porphyromonas, and Parvimonas show significant effects on FEF and FEV1 (Table 5) . Genus Veillonella shows a significant association with FEF. It appears that both Parvimonas and Veillonella in phylum Firmicutes are significantly associated with FEF and both genus Prevotella and Porphyromonas in phylum Bacteroidetes are significantly associated with FEF and FEV1. We therefore perform the test in a joint model to localize the fine cluster effect. Interestingly, by eRLRT the significant association between genus Parvimonas and FEF still remains after adjusting for the effects from genus Veillonella. But the opposite is not true. This supports the findings of the previous studies that Parvimonas abundance changed in subjects with pulmonary disease (e.g., asthma or COPD) compared to the control group (Kim et al., 2018; Pragman, Kim, Reilly, Wendt, & Isaacson, 2012) . However, either Prevotella or Porphyromonas lost its significance when adjusting for the other. This likely suggests that Prevotella and Porphyromonas are correlated and both tag effects to lung function. In comparison, LinScore only detects the significant microbiome effect of Bacteroidetes with FEF. Our results further support the conclusions from previous studies and sheds light for future clinical causality research Twigg et al., 2016; Weiden et al., 2017) . None of the tests (exact tests, LinScore, and MiRKAT) identify significant associations using only baseline data (results not shown). In conclusion, our exact tests provides innovative association evidence of pulmonary microbiome and lung function in the HIV-infected population, which have not been reported before. While the modeling is compelling, interpretation of the data and how correlations translate to meaningful clinical outcomes needs further study. In this report, motivated by a longitudinal pulmonary microbiome study, we develop and implement three computationally efficient exact variance component tests (eScore, eLRT, and eRLRT). Our method extends previous exact variance component tests to the case when the null hypothesis contains more than one variance component . They can be applied to longitudinal studies testing the overall microbiome effects, as well as cross-sectional studies identifying microbiome associations at the fine-grained level. The latter has been emerging as the focus of many current microbiome studies (Lloyd-Price et al., 2017; Nayfach, Rodriguez-Mueller, Garud, & Pollard, 2016; Truong, Tett, Pasolli, Huttenhower, & Segata, 2017) . Unlike Qu et al. (2013) and Zhao et al.'s (2015) score test that uses moment-matching to approximate null distribution, our tests are exact in finite samples, therefore Note. Type 1 error rate and power from eLRT, eRLRT, eScore, LinScore, and MiRKAT at baseline when #Repeat = 1. When #Repeat = 2, only LinScore is compared with eRLRT and eScore. Sample sizes (n) range from 20 to 100 and effect sizes (σ g 2 ) range from 0 to 1.5.
eLRT: exact likelihood ratio test; eRLRT: exact restricted likelihood ratio test; eScore: exact score test.
T A B L E 5 Application to the longitudinal pulmonary microbiome studies beneficial to studies with a limited sample size. Compared to the score test, our eLRT and eRLRT tests can further boost power when the microbiome effects are weak. Simulation studies verify that our exact tests have the correct size and many innovative utilizations. In the application to the real longitudinal pulmonary microbiome study, only our exact tests detect multiple interesting genera associated with lung function. We then further demonstrated the ability of our exact tests to differentiate associated genera by using two real data examples. Although the derivation of eLRT and eRLRT require the normality assumption, a sensitivity simulation shows that even with a misspecified phenotypic distribution, like the tdistribution, our tests still preserve the correct Type I error rate (Web Appendix E, Table 2 ). The software package is implemented in an open-source, high-performance computing language Julia and is freely available. We offer unweighted, weighted, VAW, and generalized UniFrac distance calculation to further ease the computation and advance microbiome studies.
There are a few directions for future work. First, there are linear mixed effects models not of form (3), for example, those including both random intercepts and random slopes (Drikvandi et al., 2013) . Our methods extend to these cases naturally and we defer them to future research. The second direction is to incorporate multiple types of kernels into exact tests. Finally, we consider extension to the generalized linear mixed effects models, although it can be challenging especially for LRT and RLRT. Score-based tests may be possible through penalized quasi-likelihood (H. Lin, 1997) .
| SOFTWARE
The Julia package is freely available at https://github. com/JingZhai63/VCmicrobiome. In the real longitudinal data analysis with sample size 30 and 2,964 OTUs, the elapsed CPU times are 0.1 and 0.04 s for eRLRT and eScore, respectively. The analysis was performed by a MacBook Pro with 2.3 GHz Intel Core i7 processor and 8 GB 1600 MHz DDR3 memory.
